Biolife Solutions Inc (BLFS) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Biolife Solutions Inc   (NASDAQ: BLFS)


Biolife Solutions Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Biolife Solutions Inc 's ROA in the second quarter of 2026?
Biolife Solutions Inc achieved a return on average assets (ROA) of 14.09 % in its second quarter of 2026, this is above BLFS's average return on assets of -33.28%.
Biolife Solutions Inc assets over the 12 months ending in its second quarter of 2026 are valued at $412 million

ROA has improved compared to -0.75% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 68 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 2633, from total ROA ranking in the first quarter of 2026 at 3097.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 15.56 % 1.46 % 1.85 % 7.27 % 6.45 %
Y / Y Net Income Change - - -11.15 % - -
Net Income (TTM) in million 58 -3 -5 -3 -6
Return On Assets (TTM) 14.09 % -0.75 % -1.16 % -0.82 % -1.43 %
BLFS's Total Ranking # 2633 # 3097 # 2690 # 2758 # 2907
Total Assets (TTM) in million 447 401 406 392 387
Seq. Total Assets Change 11.62 % -1.23 % 3.52 % 1.25 % -2 %
Seq. Net Income Change 3703.04 % -89.29 % 1682.61 % - -

BLFS's 5 Years Annual ROA >> Back to BLFS Management Effectiveness >> Compare BLFS ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 16
Sector # 69
Overall # 385

Return On Assets Statistics
High Average Low
30.89 %
-33.28 %
-200.69 %
(Mar 31 2018)   (Sep 30 2018)





Financial Statements
Biolife Solutions Inc 's Assets $ 447 million BLFS's Balance sheet
Biolife Solutions Inc 's Income $ 45 million Quarterly BLFS's Income Statement
BLFS's Income by Division See BLFS's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 4.59 % -5.97 % -8.33 % -18.74 % 135.94 %
Total Assets in million 406 388 413 450 554
Y / Y Net Income Change - - - - -
Net Income in million -5 -20 -66 -140 -8
Annual Return On Assets -1.13 % -5.2 % -16.1 % -31.05 % -1.38 %

BLFS's 5 Years Annual ROA >> Back to BLFS Management Effectiveness >> Compare BLFS ROA to its Competitors



More Return On Assets Ratios
BLFS's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BLFS's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BLFS's Competitors
Subscribers only: Roa for Biolife Solutions Inc 's Suppliers
Subscribers only: Return On Assets for BLFS's Customers

You may also want to know
BLFS's Roi BLFS's Inventory Turnover Ratio BLFS's Growth Rates BLFS's Dividend Comparisons
BLFS's Profitability Ratios BLFS's Asset Turnover Ratio BLFS's Dividend Growth
BLFS's Roe BLFS's Valuation Ratios BLFS's Financial Strength Ratios BLFS's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Liquidia Corporation  36.30 %
Ironwood Pharmaceuticals inc   34.34 %
Idexx Laboratories Inc  33.61 %
Tg Therapeutics Inc   33.59 %
Meiragtx Holdings Plc  29.37 %
Indivior Pharmaceuticals Inc   28.21 %
Qhslab Inc   27.12 %
Adma Biologics Inc   26.58 %
Mettler toledo International Inc   24.86 %
Medpace Holdings Inc   24.84 %
Caredx Inc   24.81 %
Acadia Pharmaceuticals Inc   24.38 %
Eli Lilly And Company  21.97 %
Innoviva Inc   21.64 %
Vaxart Inc   20.85 %
Zevra Therapeutics Inc   20.39 %
Iradimed Corporation  20.36 %
Protalix Biotherapeutics inc   20.09 %
Pro dex Inc   19.87 %
Electromed Inc   19.39 %
United Therapeutics Corporation  17.98 %
Resmed Inc   17.80 %
Krystal Biotech Inc   17.65 %
Chemed Corporation  17.52 %
Zoetis Inc   17.19 %
Vertex Pharmaceuticals Inc  16.88 %
Halozyme Therapeutics Inc   16.55 %
Alnylam Pharmaceuticals Inc   15.76 %
Intuitive Surgical Inc   15.63 %
Healthcare Services Group Inc   15.21 %

Date modified: 2026-09-08T16:49:20+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.